Motor dysfunction in a mouse model for Down syndrome.

PubWeight™: 1.19‹?› | Rank: Top 10%

🔗 View Article (PMID 10627083)

Published in Physiol Behav on January 31, 2000

Authors

A C Costa1, K Walsh, M T Davisson

Author Affiliations

1: The Jackson Laboratory, Bar Harbor, ME 04609 USA. acc@jax.org

Articles citing this

Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome. Nat Neurosci (2010) 2.08

Gait analysis detects early changes in transgenic SOD1(G93A) mice. Muscle Nerve (2005) 1.75

Transgenic overexpression of caveolin-3 in skeletal muscle fibers induces a Duchenne-like muscular dystrophy phenotype. Proc Natl Acad Sci U S A (2000) 1.31

The unipolar brush cell: a remarkable neuron finally receiving deserved attention. Brain Res Rev (2010) 1.29

Trisomy 21 and early brain development. Trends Neurosci (2011) 1.28

uPA deficiency exacerbates muscular dystrophy in MDX mice. J Cell Biol (2007) 1.22

Behavioral validation of the Ts65Dn mouse model for Down syndrome of a genetic background free of the retinal degeneration mutation Pde6b(rd1). Behav Brain Res (2009) 1.13

Comprehensive behavioral phenotyping of Ts65Dn mouse model of Down syndrome: activation of β1-adrenergic receptor by xamoterol as a potential cognitive enhancer. Neurobiol Dis (2011) 1.09

Impairments in motor coordination without major changes in cerebellar plasticity in the Tc1 mouse model of Down syndrome. Hum Mol Genet (2009) 1.09

Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome. Behav Brain Res (2010) 1.09

Elevated expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in cerebellar unipolar brush cells of a Down syndrome mouse model. Cell Mol Neurobiol (2006) 1.05

Impaired locomotor learning and altered cerebellar synaptic plasticity in pep-19/PCP4-null mice. Mol Cell Biol (2011) 1.02

Mouse models of Down syndrome as a tool to unravel the causes of mental disabilities. Neural Plast (2012) 1.00

Exaggerated NMDA mediated LTD in a mouse model of Down syndrome and pharmacological rescuing by memantine. Learn Mem (2011) 0.98

Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics (2009) 0.97

Trisomy of the G protein-coupled K+ channel gene, Kcnj6, affects reward mechanisms, cognitive functions, and synaptic plasticity in mice. Proc Natl Acad Sci U S A (2012) 0.94

Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome. Neurobiol Dis (2013) 0.93

Abnormal expression of the G-protein-activated inwardly rectifying potassium channel 2 (GIRK2) in hippocampus, frontal cortex, and substantia nigra of Ts65Dn mouse: a model of Down syndrome. J Comp Neurol (2006) 0.92

Alteration of inhibitory circuits in the somatosensory cortex of Ts65Dn mice, a model for Down's syndrome. J Neural Transm (Vienna) (2010) 0.90

Overexpression of Dyrk1A is implicated in several cognitive, electrophysiological and neuromorphological alterations found in a mouse model of Down syndrome. PLoS One (2014) 0.87

Advanced microscopic imaging methods to investigate cortical development and the etiology of mental retardation. Ment Retard Dev Disabil Res Rev (2005) 0.86

The sequence of human chromosome 21 and implications for research into Down syndrome. Genome Biol (2000) 0.86

A noradrenergic lesion exacerbates neurodegeneration in a Down syndrome mouse model. J Alzheimers Dis (2011) 0.83

Increased excitability and altered action potential waveform in cerebellar granule neurons of the Ts65Dn mouse model of Down syndrome. Brain Res (2012) 0.82

Does the learning deficit observed under an incremental repeated acquisition schedule of reinforcement in Ts65Dn mice, a model for Down syndrome, change as they age? Behav Brain Res (2009) 0.82

An assessment of the vestibulo-ocular reflex (VOR) in persons with Down syndrome. Exp Brain Res (2011) 0.81

Size does not always matter: Ts65Dn Down syndrome mice show cerebellum-dependent motor learning deficits that cannot be rescued by postnatal SAG treatment. J Neurosci (2013) 0.81

The cognitive phenotype of Down syndrome: insights from intracellular network analysis. NeuroRx (2006) 0.80

Opposite phenotypes of muscle strength and locomotor function in mouse models of partial trisomy and monosomy 21 for the proximal Hspa13-App region. PLoS Genet (2015) 0.79

Working memory in the aged Ts65Dn mouse, a model for Down syndrome. Behav Brain Res (2012) 0.77

Down Syndrome Cognitive Phenotypes Modeled in Mice Trisomic for All HSA 21 Homologues. PLoS One (2015) 0.77

Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome. Sci Rep (2011) 0.77

Weaker control of the electrical properties of cerebellar granule cells by tonically active GABAA receptors in the Ts65Dn mouse model of Down's syndrome. Mol Brain (2013) 0.75

Digastric Muscle Phenotypes of the Ts65Dn Mouse Model of Down Syndrome. PLoS One (2016) 0.75

Hypocellularity in the Murine Model for Down Syndrome Ts65Dn Is Not Affected by Adult Neurogenesis. Front Neurosci (2016) 0.75

OPA1 deficiency promotes secretion of FGF21 from muscle that prevents obesity and insulin resistance. EMBO J (2017) 0.75

Articles by these authors

(truncated to the top 100)

The Mouse Genome Database (MGD): expanding genetic and genomic resources for the laboratory mouse. The Mouse Genome Database Group. Nucleic Acids Res (2000) 20.44

Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature (1999) 11.37

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals. Nat Med (2000) 5.72

Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice. Nat Genet (1997) 5.13

Akt promotes survival of cardiomyocytes in vitro and protects against ischemia-reperfusion injury in mouse heart. Circulation (2000) 4.96

A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet (1995) 4.95

Emergence of brown adipocytes in white fat in mice is under genetic control. Effects on body weight and adiposity. J Clin Invest (1998) 4.94

Retinal degeneration mutants in the mouse. Vision Res (2002) 4.93

Primary structure and functional expression of the beta 1 subunit of the rat brain sodium channel. Science (1992) 4.44

The Mouse Genome Database (MGD): genetic and genomic information about the laboratory mouse. The Mouse Genome Database Group. Nucleic Acids Res (1999) 4.39

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb. Lancet (1996) 4.32

The Mouse Genome Database (MGD). A comprehensive public resource of genetic, phenotypic and genomic data. The Mouse Genome Informatics Group. Nucleic Acids Res (1997) 4.31

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation (1998) 4.10

Akt mediates cytoprotection of endothelial cells by vascular endothelial growth factor in an anchorage-dependent manner. J Biol Chem (1999) 3.76

Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol (1996) 3.71

Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. J Mol Cell Cardiol (2001) 3.66

Mapping point mutations in the Drosophila rosy locus using denaturing gradient gel blots. Genetics (1991) 3.66

MyoD-induced expression of p21 inhibits cyclin-dependent kinase activity upon myocyte terminal differentiation. Mol Cell Biol (1995) 3.32

Transcatheter occlusion of foramen ovale with a button device after neurological decompression illness in professional divers. Lancet (1996) 3.27

Back pain in Britain: comparison of two prevalence surveys at an interval of 10 years. BMJ (2000) 2.73

Rules and guidelines for mouse gene nomenclature: a condensed version. International Committee on Standardized Genetic Nomenclature for Mice. Genomics (1997) 2.65

The branch point effect. Ultrasensitivity and subsensitivity to metabolic control. J Biol Chem (1984) 2.54

Reactive oxygen species mediate the activation of Akt/protein kinase B by angiotensin II in vascular smooth muscle cells. J Biol Chem (1999) 2.46

Mutations in the human orthologue of the mouse underwhite gene (uw) underlie a new form of oculocutaneous albinism, OCA4. Am J Hum Genet (2001) 2.43

Differential expression of a new dominant agouti allele (Aiapy) is correlated with methylation state and is influenced by parental lineage. Genes Dev (1994) 2.41

Vascular endothelial growth factor-stimulated actin reorganization and migration of endothelial cells is regulated via the serine/threonine kinase Akt. Circ Res (2000) 2.39

Alveolar macrophage activation and an emphysema-like phenotype in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol (2008) 2.30

Interacting loci cause severe iris atrophy and glaucoma in DBA/2J mice. Nat Genet (1999) 2.30

Two mouse retinal degenerations caused by missense mutations in the beta-subunit of rod cGMP phosphodiesterase gene. Vision Res (2007) 2.29

Dietary calcium, physical activity, and risk of hip fracture: a prospective study. BMJ (1989) 2.24

A prospective cytogenetic study of 36 cases of DiGeorge syndrome. Am J Hum Genet (1992) 2.23

The Mouse Genome Database (MGD): a community resource. Status and enhancements. The Mouse Genome Informatics Group. Nucleic Acids Res (1998) 2.20

HMG-CoA reductase inhibitor mobilizes bone marrow--derived endothelial progenitor cells. J Clin Invest (2001) 2.20

Results of balloon pulmonary valvuloplasty as a palliative procedure in tetralogy of Fallot. J Am Coll Cardiol (1991) 2.10

Murine mucopolysaccharidosis type VII. Characterization of a mouse with beta-glucuronidase deficiency. J Clin Invest (1989) 2.09

Defective pro alpha 2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci U S A (1993) 2.07

Molecular analysis of reverse mutations from nonagouti (a) to black-and-tan (a(t)) and white-bellied agouti (Aw) reveals alternative forms of agouti transcripts. Genes Dev (1994) 2.07

Branch point control by the phosphorylation state of isocitrate dehydrogenase. A quantitative examination of fluxes during a regulatory transition. J Biol Chem (1985) 2.06

Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science (1996) 2.03

Two nuclear factors compete for the skeletal muscle actin promoter. J Biol Chem (1987) 2.02

FLICE-inhibitory protein expression during macrophage differentiation confers resistance to fas-mediated apoptosis. J Exp Med (1999) 1.92

The fatty liver dystrophy (fld) mutation. A new mutant mouse with a developmental abnormality in triglyceride metabolism and associated tissue-specific defects in lipoprotein lipase and hepatic lipase activities. J Biol Chem (1989) 1.91

Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. Circulation (1997) 1.91

Functional antagonism between YY1 and the serum response factor. Mol Cell Biol (1992) 1.91

Determination of flux through the branch point of two metabolic cycles. The tricarboxylic acid cycle and the glyoxylate shunt. J Biol Chem (1984) 1.91

Informatics for mouse genetics and genome mapping. Methods (1998) 1.89

Transcatheter closure of atrial septal defect and interatrial communications with a new self expanding nitinol double disc device (Amplatzer septal occluder): multicentre UK experience. Heart (1999) 1.88

A deletion in a photoreceptor-specific nuclear receptor mRNA causes retinal degeneration in the rd7 mouse. Proc Natl Acad Sci U S A (2000) 1.88

Cell cycle withdrawal promotes myogenic induction of Akt, a positive modulator of myocyte survival. Mol Cell Biol (1999) 1.81

Sphingosine 1-phosphate activates Akt, nitric oxide production, and chemotaxis through a Gi protein/phosphoinositide 3-kinase pathway in endothelial cells. J Biol Chem (2001) 1.72

Characterization of rate-controlling steps in vivo by use of an adjustable expression vector. Proc Natl Acad Sci U S A (1985) 1.69

Cloning, chromosomal localization and expression analysis of the mouse Akt2 oncogene. Oncogene (1995) 1.67

Akt down-regulation of p38 signaling provides a novel mechanism of vascular endothelial growth factor-mediated cytoprotection in endothelial cells. J Biol Chem (2001) 1.65

Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes. Diabetes Care (1999) 1.65

Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J Biol Chem (2001) 1.64

p21CIP1-mediated inhibition of cell proliferation by overexpression of the gax homeodomain gene. Genes Dev (1997) 1.63

Retinal degeneration 6 (rd6): a new mouse model for human retinitis punctata albescens. Invest Ophthalmol Vis Sci (2000) 1.61

Pulse oximetry: a new non-invasive assessment of peripheral arterial occlusive disease. Br J Surg (1990) 1.57

Adenoviral constructs encoding phosphorylation-competent full-length and truncated forms of the human retinoblastoma protein inhibit myocyte proliferation and neointima formation. Circulation (1997) 1.57

Acute modulation of endothelial Akt/PKB activity alters nitric oxide-dependent vasomotor activity in vivo. J Clin Invest (2000) 1.56

Ts65Dn -- localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome. Cytogenet Cell Genet (2001) 1.52

Cyclin A downregulation and p21(cip1) upregulation correlate with GATA-6-induced growth arrest in glomerular mesangial cells. Circ Res (2000) 1.52

Abnormal nonshivering thermogenesis in mice with inherited defects of fatty acid oxidation. J Clin Invest (1998) 1.50

Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction. Circulation (2001) 1.44

Molecular cloning of a diverged homeobox gene that is rapidly down-regulated during the G0/G1 transition in vascular smooth muscle cells. Mol Cell Biol (1993) 1.44

Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J Biol Chem (2000) 1.42

The mouse mutation severe combined immune deficiency (scid) is on chromosome 16. Immunogenetics (1989) 1.41

The mouse brain transcriptome by SAGE: differences in gene expression between P30 brains of the partial trisomy 16 mouse model of Down syndrome (Ts65Dn) and normals. Genome Res (2000) 1.40

Different regulatory sequences control creatine kinase-M gene expression in directly injected skeletal and cardiac muscle. Mol Cell Biol (1993) 1.38

Midazolam infusion in a pediatric intensive care unit. Ann Pharmacother (1993) 1.38

Intracoronary, adenovirus-mediated Akt gene transfer in heart limits infarct size following ischemia-reperfusion injury in vivo. J Mol Cell Cardiol (2000) 1.37

Stargazer: a new neurological mutant on chromosome 15 in the mouse with prolonged cortical seizures. Epilepsy Res (1990) 1.37

Mouse models of ocular diseases. Vis Neurosci (2005) 1.37

Rb functions to inhibit apoptosis during myocyte differentiation. Cancer Res (1997) 1.35

TNFalpha regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation. Nat Med (1998) 1.34

Application of a computerized medical decision-making process to the problem of digoxin intoxication. J Am Coll Cardiol (1984) 1.33

Synaptonemal complex analysis of mouse chromosomal rearrangements. IV. Synapsis and synaptic adjustment in two paracentric inversions. Chromosoma (1982) 1.32

Phosphatidylinositol 3-kinase/Akt signaling controls endothelial cell sensitivity to Fas-mediated apoptosis via regulation of FLICE-inhibitory protein (FLIP). Circ Res (2001) 1.31

Relationship between volumes and areas from single transverse scans of intra-abdominal fat measured by magnetic resonance imaging. Int J Obes Relat Metab Disord (1997) 1.30

Inhibition of myogenesis by multiple cyclin-Cdk complexes. Coordinate regulation of myogenesis and cell cycle activity at the level of E2F. J Biol Chem (1997) 1.25

The human GATA-6 gene: structure, chromosomal location, and regulation of expression by tissue-specific and mitogen-responsive signals. Genomics (1996) 1.25

Impact of human immunodeficiency virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Arch Clin Neuropsychol (2000) 1.24

GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest. J Biol Chem (1998) 1.24

Follow-up results of transvenous occlusion of patent ductus arteriosus with the buttoned device. J Am Coll Cardiol (1999) 1.23

Oxidized LDL activates fas-mediated endothelial cell apoptosis. J Clin Invest (1998) 1.23

Identification of single-stranded-DNA-binding proteins that interact with muscle gene elements. Mol Cell Biol (1991) 1.22

Detection of Potato mop top virus and Tobacco rattle virus Using a Multiplex Real-Time Fluorescent Reverse-Transcription Polymerase Chain Reaction Assay. Phytopathology (2000) 1.21

'Wasted', a new mutant of the mouse with abnormalities characteristic to ataxia telangiectasia. Nature (1982) 1.20

In utero pacing for fetal congenital heart block. Fetal Diagn Ther (1994) 1.19

Scrambler, a new neurological mutation of the mouse with abnormalities of neuronal migration. Mamm Genome (1996) 1.17

A new spontaneous mouse mutation of Hoxd13 with a polyalanine expansion and phenotype similar to human synpolydactyly. Hum Mol Genet (1998) 1.17

A frameshift mutation in the mouse alpha 1 glycine receptor gene (Glra1) results in progressive neurological symptoms and juvenile death. Hum Mol Genet (1994) 1.17

Activated Akt protects the lung from oxidant-induced injury and delays death of mice. J Exp Med (2001) 1.15

Decorin-mediated signal transduction in endothelial cells. Involvement of Akt/protein kinase B in up-regulation of p21(WAF1/CIP1) but not p27(KIP1). J Biol Chem (2001) 1.15

An inhibitory role of the phosphatidylinositol 3-kinase-signaling pathway in vascular endothelial growth factor-induced tissue factor expression. J Biol Chem (2001) 1.15

Chromosomal localization of the murine gene and two related sequences encoding high-mobility-group I and Y proteins. Genomics (1992) 1.13

Incidence and prognosis of obstruction of the left ventricular outflow tract in Liverpool (1960-91): a study of 313 patients. Br Heart J (1994) 1.12

Sandy: a new mouse model for platelet storage pool deficiency. Genet Res (1991) 1.12

Evolution of mammalian carbonic anhydrase loci by tanden duplication: close linkage of Car-1 and Car-2 to the centromere region of chromosome 3 of the mouse. Biochem Genet (1976) 1.11

Nitric oxide-induced downregulation of Cdk2 activity and cyclin A gene transcription in vascular smooth muscle cells. Circulation (1998) 1.11